Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 19 Lung Neoplasms 10 Stomach Neoplasms 8 Neoplasm Metastasis 7 Colorectal Neoplasms 6 Breast Neoplasms 6 Nasopharyngeal Carcinoma 5 Leukemia, Myeloid, Acute 5 Esophageal Neoplasms 5 Triple Negative Breast Neoplasms 4 Small Cell Lung Carcinoma 4 Pancreatic Neoplasms 4 Neoplasms 4 Uterine Cervical Neoplasms 3 Ovarian Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Endometrial Neoplasms 3 Adenocarcinoma Of Esophagus 3 Urinary Bladder Neoplasms 2 Rectal Neoplasms 2 Mouth Neoplasms 2 Lymphoma 2 Head and Neck Neoplasms 2 Glioma 2 Glioblastoma 2 Carcinoma, Squamous Cell 2 Anatomic Stage II Breast Cancer AJCC v8 2 Advanced Solid Tumors 2 Unresectable Locally Recurrent Rectal Cancer 1 Thymoma 1

Interventions

Doxorubicin 13 Specimen Handling 12 pembrolizumab 11 Magnetic Resonance Spectroscopy 10 Biopsy 10 Cyclophosphamide 9 X-Rays 7 Ifosfamide 7 Radiotherapy 6 Phantoms, Imaging 6 Gemcitabine 6 liposomal doxorubicin 5 Nivolumab 5 tazemetostat 4 palbociclib 4 fludarabine 4 atezolizumab 4 Temozolomide 4 Radiation 4 Nuclear Medicine Department, Hospital 4 Irinotecan 4 larotrectinib 3 cabozantinib 3 Surveys and Questionnaires 3 Ipilimumab 3 Carboplatin 3 Bevacizumab 3 ulixertinib 2 tipifarnib 2 selpercatinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × Drug Therapy × 90 days × Clear all

NCT04307277 2026-04-14

CHIC-STS01

Institut Claudius Regaud

Phase 3 Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡